Singapore, Singapore
Singapore Permanent Resident (PR). Commercially focused operations executive with a proven record of scaling technology companies and delivering organisation-wide performance improvements. I build operating models that increase efficiency, strengthen execution and enable international growth. I have led companies from early-stage through to a USD 4 billion IPO, overseeing the establishment of core functions, global team structures and scalable processes. My work has improved unit economics, reduced operational risk and supported revenue expansion across multiple markets. Engineer by training, I apply structured problem-solving, data-driven decision-making and disciplined prioritisation. I focus on measurable outcomes: faster delivery, lower cost, higher quality and stronger cross-functional alignment. I am suited to executive roles where commercial performance, operational rigour and scalable systems are central to sustaining growth and improving margins.
An open marketplace that brings together the people, tools, and services needed for clinical research in one place; removing the confusion of clinical trials and enabling health and biotech pioneers to take more ownership of clinical development from conception to post-market.
Global technology company, valued at >$1.7bn, focused on privacy-first digital security software. Kape Technologies provides a suite of solutions to protect consumers' digital lives and includes ExpressVPN, Private Internet Access and CyberGhost within its portfolio.
Strategic Product Builder, specialising in providing outsourced developers and UI/UX resources across leading FinTech, HealthTech, InsureTech and ESGTech organisations.
UK headquartered biotechnology start-up backed by the University of Oxford, Innovate UK and Hoxton Ventures; created the world’s first mutation-proof saliva COVID-19 lateral flow device.